Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Skin Carcinoma 1Carcinoma, Renal Cell 1

Interventions

pembrolizumab 1254Specimen Handling 869Carboplatin 818Magnetic Resonance Spectroscopy 804Cyclophosphamide 795Cisplatin 716Nivolumab 648Paclitaxel 623Radiotherapy 567Gemcitabine 565Biopsy 529Bevacizumab 468Dexamethasone 434fludarabine 404Docetaxel 373venetoclax 366Oxaliplatin 362Capecitabine 353Fluorouracil 352atezolizumab 341Rituximab 327durvalumab 326Doxorubicin 313Radiosurgery 306Pemetrexed 303Drug Therapy 295Standard of Care 292Ipilimumab 290Etoposide 280Radiation 278

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Aftercare × 1 year × Clear all
NCT00918775 2026-04-15

Follow-up After Metastasectomy in Patients With Kidney Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
86 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT07032701 2026-04-02

A Disposable Negative Pressure Wound Therapy Device (SNaP) to Promote Wound Healing in the Lower Limbs Following Mohs Micrographic Surgery for Non-melanoma Skin Cancer

Jonsson Comprehensive Cancer Center

Phase NA Not yet recruiting
60 enrolled

Skin Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡